Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
Clinical trial NCT06918015 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06918015
- Sponsor
- Zhejiang Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2028-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.